Cargando…

The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity

The classification of T helper cells into type 1 (Th1) and type 2 (Th2) led to the hypothesis that Th1 cells and their cytokines (interleukin [IL]-2, interferon [IFN]-γ) are involved in cell-mediated autoimmune diseases, and that Th2 cells and their cytokines (IL-4, IL-5, IL-10, IL-13) are involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Theofilopoulos, Argyrios N, Koundouris, Stefanos, Kono, Dwight H, Lawson, Brian R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128889/
https://www.ncbi.nlm.nih.gov/pubmed/11299053
http://dx.doi.org/10.1186/ar290
_version_ 1782120350066147328
author Theofilopoulos, Argyrios N
Koundouris, Stefanos
Kono, Dwight H
Lawson, Brian R
author_facet Theofilopoulos, Argyrios N
Koundouris, Stefanos
Kono, Dwight H
Lawson, Brian R
author_sort Theofilopoulos, Argyrios N
collection PubMed
description The classification of T helper cells into type 1 (Th1) and type 2 (Th2) led to the hypothesis that Th1 cells and their cytokines (interleukin [IL]-2, interferon [IFN]-γ) are involved in cell-mediated autoimmune diseases, and that Th2 cells and their cytokines (IL-4, IL-5, IL-10, IL-13) are involved in autoantibody(humoral)-mediated autoimmune diseases. However, this paradigm has been refuted by recent studies in several induced and spontaneous mouse models of systemic lupus erythematosus, which showed that IFN-γ is a major effector molecule in this disease. These and additional findings, reviewed here, suggest that these two cross-talking classes of cytokines can exert autoimmune disease-promoting or disease-inhibiting effects without predictability or strict adherence to the Th1-versus-Th2 dualism.
format Text
id pubmed-128889
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1288892002-10-28 The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity Theofilopoulos, Argyrios N Koundouris, Stefanos Kono, Dwight H Lawson, Brian R Arthritis Res Commentary The classification of T helper cells into type 1 (Th1) and type 2 (Th2) led to the hypothesis that Th1 cells and their cytokines (interleukin [IL]-2, interferon [IFN]-γ) are involved in cell-mediated autoimmune diseases, and that Th2 cells and their cytokines (IL-4, IL-5, IL-10, IL-13) are involved in autoantibody(humoral)-mediated autoimmune diseases. However, this paradigm has been refuted by recent studies in several induced and spontaneous mouse models of systemic lupus erythematosus, which showed that IFN-γ is a major effector molecule in this disease. These and additional findings, reviewed here, suggest that these two cross-talking classes of cytokines can exert autoimmune disease-promoting or disease-inhibiting effects without predictability or strict adherence to the Th1-versus-Th2 dualism. BioMed Central 2001 2001-02-14 /pmc/articles/PMC128889/ /pubmed/11299053 http://dx.doi.org/10.1186/ar290 Text en Copyright © 2001 BioMed Central Ltd
spellingShingle Commentary
Theofilopoulos, Argyrios N
Koundouris, Stefanos
Kono, Dwight H
Lawson, Brian R
The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
title The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
title_full The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
title_fullStr The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
title_full_unstemmed The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
title_short The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity
title_sort role of ifn-gamma in systemic lupus erythematosus: a challenge to the th1/th2 paradigm in autoimmunity
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128889/
https://www.ncbi.nlm.nih.gov/pubmed/11299053
http://dx.doi.org/10.1186/ar290
work_keys_str_mv AT theofilopoulosargyriosn theroleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity
AT koundourisstefanos theroleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity
AT konodwighth theroleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity
AT lawsonbrianr theroleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity
AT theofilopoulosargyriosn roleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity
AT koundourisstefanos roleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity
AT konodwighth roleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity
AT lawsonbrianr roleofifngammainsystemiclupuserythematosusachallengetotheth1th2paradigminautoimmunity